Results for tag: "Gliclazide"

Gliclazide is a drug used to treat type 2 diabetes, a condition in which the body does not produce enough insulin or does not use insulin properly. It belongs to a class of drugs known as sulfonylureas, which work by stimulating the pancreas to produce more insulin. Gliclazide is also used to treat hematological disorders, such as anemia, thrombocytopenia, and neutropenia. It works by increasing the production of red blood cells, platelets, and white blood cells. Gliclazide is available in both oral and injectable forms. It is usually taken once or twice a day, depending on the condition being treated. Common side effects include nausea, vomiting, diarrhea, and headache. More serious side effects may include low blood sugar, liver damage, and allergic reactions. The gliclazide market is highly competitive, with many companies offering generic and branded versions of the drug. Some of the major players in the market include Novartis, Sanofi, Merck, Pfizer, and GlaxoSmithKline. Show Less Read more